5/10
Research
Uncovering unexpected properties in a complex quantum material
Using a novel technique developed at Penn, researchers gained new insights into the properties of a proposed excitonic insulator known as Ta2NiSe5, with implications for future quantum devices.
A serendipitous finding lends new insight into how atopic dermatitis develops
Research from the School of Dental Medicine, the Perelman School of Medicine, and Oak Ridge National Laboratory reveals a mechanism behind the inflammation that is a feature of the common skin disease.
Context-dependent behavior can make cooperation flourish
Recent studies led by School of Arts & Sciences’ researchers show that changing social strategies between settings—for example, cooperating at home but not at work—can in fact lead to more cooperative behavior in a society.
New antiviral drug combination is highly effective against SARS-CoV-2
A Penn Medicine study finds that combining remdesivir or molnupiravir with the experimental drug brequinar blocked the replication of the virus that causes COVID-19 in lung cells.
Decade-long remission after CAR T cell therapy
Two patients represent longest-known CAR T cell response to date, providing insight into treatment effect and outcomes.
Why are alcohol- and drug-related deaths rising in the U.S. and not elsewhere?
With insights from anthropology and neuroscience, Penn researchers Michael Platt and Peter Sterling find that, in comparison, 16 other wealthy nations offer communal assistance at every life stage, support that protects individuals and families long term.
Studying the past through a modern-day lens
In a Q & A, archaeologist and PIK Professor Lynn Meskell discusses her background, the subjects that interest her—from espionage to World Heritage sites—and collaborations that have organically arisen at Penn despite the pandemic and a mostly remote first year.
Hard barriers and soft power: Study assesses outsider perceptions of border walls
Two researchers explore how border walls damage a country’s international image, with real soft power implications.
Ten from Penn elected 2021 AAAS Fellows
Ten scholars representing five schools across the University of Pennsylvania have been named to the 2021 class of American Association for the Advancement of Science Fellows, recognized for their “scientifically and socially distinguished achievements.”
A novel theory on how conspiracy theories take shape
In a new book, Dolores Albarracín, Kathleen Hall Jamieson, and colleagues show that two factors—the conservative media and societal fear and anxiety—have driven recent widespread conspiracies, from Pizzagate to those around COVID-19 vaccines.
In the News
The quest for treatments to keep weight off after Ozempic
Researchers at Penn are conducting a co-authored study of the brains, fat and muscle cells, and eating patterns of people trying to maintain new body sizes.
FULL STORY →
There’s still no standard test to detect pancreatic cancer early. Scientists are working to change that
A 2020 study from the Perelman School of Medicine found that a blood test to screen for certain biomarkers associated with pancreatic cancer was 92% accurate in its ability to detect disease.
FULL STORY →
Hedge funder famous for his ‘black swan’ strategy says there’s ‘something immoral’ about America’s reliance on debt—and future generations ‘will bear the burden for this’
A 2023 study by the Wharton School found that the U.S. has about 20 years left for corrective action to fix the national debt before it hits 200% of GDP.
FULL STORY →
Can money buy you happiness? Yes, it can. However…
Research by Matthew Killingsworth of the Wharton School reveals there is no monetary threshold at which money's capacity to improve well-being diminishes.
FULL STORY →
Sugar-coated gold nanoparticles could replace some antibiotics
According to a Penn Medicine study, a new therapy involving laser light and sugar-coated gold nanoparticles can reduce tooth decay and infected wounds without needing antibiotics.
FULL STORY →
A new strategy to attack aggressive brain cancer shrank tumors in two early tests
A clinical trial led by Stephen Bagley of the Perelman School of Medicine suggests that targeting two associated proteins with CAR T cell therapy could be a viable strategy for shrinking brain tumors.
FULL STORY →